Syros Pharmaceuticals, Inc.

NasdaqGS:SYRS Stock Report

Market Cap: US$42.1m

Syros Pharmaceuticals Ownership

Who are the major shareholders and have insiders been buying or selling?


Recent Insider Transactions

NasdaqGS:SYRS Recent Insider Transactions by Companies or Individuals
DateValueNameEntityRoleSharesMax Price
12 Sep 24BuyUS$161,240Jason HaasIndividual100,000US$1.68
11 Sep 24BuyUS$160,680Conley CheeIndividual100,000US$1.71
21 Dec 23BuyUS$3,999,998Samsara BioCapital LLCCompany904,977US$4.42

Insider Trading Volume

Insider Buying: SYRS insiders have bought more shares than they have sold in the past 3 months.


Ownership Breakdown

What is the ownership structure of SYRS?
Owner TypeNumber of SharesOwnership Percentage
Individual Insiders403,3811.5%
General Public5,011,36218.7%
Hedge Funds5,221,10319.5%
VC/PE Firms7,041,24826.3%
Institutions9,132,67034.1%

Dilution of Shares: Shareholders have been diluted in the past year, with total shares outstanding growing by 29.5%.


Top Shareholders

Top 25 shareholders own 76.05% of the company
OwnershipNameSharesCurrent ValueChange %Portfolio %
10.3%
Bain Capital Life Sciences Investors, LLC
2,749,808US$4.3m0%0.45%
9.34%
Artal Group S.A.
2,505,013US$3.9m0%0.1%
7.73%
Adage Capital Management, L.P.
2,071,914US$3.3m0%0.01%
6.66%
Samsara BioCapital LLC
1,786,427US$2.8m0%0.49%
6.24%
Avidity Partners Management, L.P.
1,673,538US$2.6m0%0.1%
5.5%
Point72 Asset Management, L.P.
1,475,651US$2.3m0.26%0.01%
4.83%
Flagship Pioneering, Inc
1,293,849US$2.0m0%0.3%
3.61%
The Vanguard Group, Inc.
968,217US$1.5m4.33%no data
3.23%
Opaleye Management Inc.
865,443US$1.4m9.89%0.24%
3.09%
Deep Track Capital, LP
828,485US$1.3m0%0.03%
1.98%
Cowen Inc,Private Banking and Investment Banking Investments
531,914US$835.1k0%0.02%
1.69%
Medical Strategy GmbH, Asset Management Arm
451,832US$709.4k-14.5%0.04%
1.59%
Kennedy Capital Management LLC
427,536US$671.2k5.59%0.01%
1.27%
CHI Advisors LLC
340,855US$535.1k0%0.19%
1.07%
Walleye Capital LLC
285,803US$448.7k0.3%no data
1.04%
UBS O'Connor LLC
278,103US$436.6k58.9%0.03%
0.98%
ExodusPoint Capital Management, LP
263,691US$414.0k70.1%no data
0.98%
Goldman Sachs Group, Investment Banking and Securities Investments
262,373US$411.9k-41.3%no data
0.97%
BlackRock, Inc.
259,189US$406.9k0.84%no data
0.94%
Omega Fund Management, LLC
251,270US$394.5k0%0.3%
0.84%
Geode Capital Management, LLC
226,110US$355.0k2.66%no data
0.6%
Marshall Wace LLP
160,390US$251.8k0.51%no data
0.59%
Exome Asset Management LLC
159,175US$249.9k0%0.22%
0.51%
Dafna Capital Management, LLC
135,850US$213.3k0%0.05%
0.51%
Nancy Simonian
135,658US$213.0k35.5%no data